Purcell Lynn Sebastian
Known title: DirectorCIK: 0002128469
Purcell Lynn Sebastian's purchase track record
Purcell Lynn Sebastian has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/18/2026 | CNXU | $162K | -60.1% | pending | — |
| 5/12/2026 | CNXU | $338K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CNXU | ▼ Sell | Other | 217,608 | $500K | 9/4/2026 | View on chart |
| CNXU | ▲ Buy | Open Market | 202,500 | $162K | 6/18/2026 | View on chart |
| CNXU | ▲ Buy | Open Market | 422,500 | $338K | 5/12/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
CNXU Provides Update on FDA 510(k) Program for Wound Care Device
Conexeu Sciences released an update describing its regulatory and manufacturing program that supports a planned FDA 510(k) premarket notification for a ten‑minute tissue, lead wound‑care device candidate. The announcement signals progress toward filing the notification and may affect the timeline for potential market entry. The stock is currently near a support level of $9.62 and has an RSI of 31.4, suggesting limited momentum.
CNXU Provides Update on FDA 510(k) Program for Wound Care Device. Conexeu Sciences released an update describing its regulatory and manufacturing program that supports a planned FDA 510(k) premarket notification for a ten‑minute tissue, lead wound‑care device candidate. The announcement signals progress toward filing the notification and may affect the timeline for potential market entry. The stock is currently near a support level of $9.62 and has an RSI of 31.4, suggesting limited momentum.